Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PDE2A |
| Upstream (Parents) |
|---|
| (<<) ADRBK2 → PDE2A |
| (<<) AKAP12 → PDE2A |
| (<<) CAV1 → PDE2A |
| (<<) CEBPD → PDE2A |
| (<<) CLDN5 → PDE2A |
| (<<) DUSP2 → PDE2A |
| (<<) GNG11 → PDE2A |
| (<<) IGFBP7 → PDE2A |
| (<<) ITGA7 → PDE2A |
| (<<) KLF2 → PDE2A |
| (<<) RECK → PDE2A |
| Downstream (Children) |
|---|
| PDE2A → ADCY4 (>>) |
| PDE2A → ATP2C1 (>>) |
| PDE2A → BBS1 (>>) |
| PDE2A → CACNA1I (>>) |
| PDE2A → CCNL1 (>>) |
| PDE2A → CHST7 (>>) |
| PDE2A → CXCL14 (>>) |
| PDE2A → CXCL2 (>>) |
| PDE2A → CYP1B1 (>>) |
| PDE2A → EFEMP1 (>>) |
| PDE2A → EGR1 (>>) |
| PDE2A → ETS2 (>>) |
| PDE2A → FGF7 (>>) |
| PDE2A → G0S2 (>>) |
| PDE2A → HDAC2 (>>) |
| PDE2A → HS2ST1 (>>) |
| PDE2A → IL1R1 (>>) |
| PDE2A → MAP3K9 (>>) |
| PDE2A → NET1 (>>) |
| PDE2A → NGFR (>>) |
| PDE2A → PIK3C2B (>>) |
| PDE2A → PPAP2A (>>) |
| PDE2A → SCN4B (>>) |
| PDE2A → SOX17 (>>) |
| PDE2A → STAM2 (>>) |
| PDE2A → STAT6 (>>) |
| PDE2A → TFPI2 (>>) |
| PDE2A → THRB (>>) |
| PDE2A → TMEM88 (>>) |
| PDE2A → TNXB (>>) |
